ADRIACIN Side Effects

6959252-6 | Frontotemporal Dementia
on Aug 20, 2010 Male patient from JAPAN , 40 years of age, was diagnosed with hodgkin's disease (What is hodgkin's disease?), depression (What is depression?) and was treated with Adriacin (View Usage). Patient experienced the following unwanted or unexpected effects: frontotemporal dementia. Adriacin dosage: 40 Mg. During the same period patient was treated with VINBLASTINE SULFATE (10 Mg) (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), BLEO (15 Mg, Unk) (View Bleo Review and Bleo Label ), DACARBAZINE (400 Mg, Unk) (View Dacarbazine Review and Dacarbazine Label ), PAXIL (10 Mg, 1x/day) (View Paxil Review and Paxil Label ), TOLEDOMIN (100 Mg, 1x/day) (View Toledomin Review and Toledomin Label ).

6944831-2 | Upper Respiratory Tract Inflammation
Patient was taking Adriacin (View Usage). Patient had the following side effects: upper respiratory tract inflammation on Aug 17, 2010 from JAPAN Additional patient health information: Female patient , 52 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Adriacin dosage: 85 Mg Ij. During the same period patient was treated with TAXOTERE (128 Mg Ij) (View Taxotere Review and Taxotere Label ), ENDOXAN (855 Mg Ij) (View Endoxan Review and Endoxan Label ), FAMOTIDINE (20 Mg, 2x/day) (View Famotidine Review and Famotidine Label ), MUCOSTA (100 Mg, 3x/day) (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

6943355-6 | Frontotemporal Dementia
Adverse event was reported on Aug 18, 2010 by a Male patient taking Adriacin (View Usage) (Dosage: 40 Mg) was diagnosed with hodgkin's disease (What is hodgkin's disease?), depression (What is depression?) and. Location: JAPAN , 40 years of age, After Adriacin was administered, patient had the following side effects: frontotemporal dementia. During the same period patient was treated with VINBLASTINE SULFATE (10 Mg) (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), BLEO (15 Mg, Unk) (View Bleo Review and Bleo Label ), DACARBAZINE (400 Mg, Unk) (View Dacarbazine Review and Dacarbazine Label ), PAXIL (10 Mg, 1x/day) (View Paxil Review and Paxil Label ), TOLEDOMIN (100 Mg, 1x/day) (View Toledomin Review and Toledomin Label ).

6930585-2 | Frontotemporal Dementia
on Aug 06, 2010 Male patient from JAPAN , 40 years of age, was diagnosed with hodgkin's disease (What is hodgkin's disease?), depression (What is depression?) and was treated with Adriacin (View Usage). Patient experienced the following unwanted or unexpected effects: frontotemporal dementia. Adriacin dosage: 40 Mg. During the same period patient was treated with VINBLASTINE SULFATE (10 Mg) (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), BLEO (15 Mg, Unk) (View Bleo Review and Bleo Label ), DACARBAZINE (400 Mg, Unk) (View Dacarbazine Review and Dacarbazine Label ), PAXIL (10 Mg, 1x/day) (View Paxil Review and Paxil Label ), TOLEDOMIN (100 Mg, 1x/day) (View Toledomin Review and Toledomin Label ).


6848233-9 | Pneumonia
on Jul 06, 2010 Female patient from JAPAN , 33 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Adriacin (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Adriacin dosage: 50 Mg/m2, Ij. During the same period patient was treated with CYCLOPHOSPHAMIDE (500 Mg/m2, Ij) (View Cyclophosphamide Review and Cyclophosphamide Label ), TAXOTERE (75 Mg/m2, Ij) (View Taxotere Review and Taxotere Label ), KRN125 (1.8 Mg, Unk) (View Krn125 Review and Krn125 Label ), DEPAS (0.5 Mg, Unk) (View Depas Review and Depas Label ), PRIMPERAN TAB (5 Mg, 3x/day) (View Primperan Tab Review and Primperan Tab Label ), NOVAMIN (5 Mg, 3x/day) (View Novamin Review and Novamin Label ). Patient was hospitalized.

6841547-8 | Frontotemporal Dementia
Patient was taking Adriacin (View Usage). After Adriacin was administered, patient had the following side effects: frontotemporal dementia on Jun 30, 2010 from JAPAN Additional patient health information: Male patient , 39 years of age, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Adriacin dosage: 40 Mg. During the same period patient was treated with VINBLASTINE SULFATE (10 Mg,) (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), BLEO (15 Mg, Unk) (View Bleo Review and Bleo Label ), DACARBAZINE (400 Mg, Unk) (View Dacarbazine Review and Dacarbazine Label ).

6836438-2 | Pneumonia
Adverse event was reported on Jun 29, 2010 by a Female patient taking Adriacin (View Usage) (Dosage: 50 Mg/m2, Ij) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 33 years of age, Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?). During the same period patient was treated with CYCLOPHOSPHAMIDE (500 Mg/m2, Ij) (View Cyclophosphamide Review and Cyclophosphamide Label ), TAXOTERE (75 Mg/m2, Ij) (View Taxotere Review and Taxotere Label ), KRN125 (1.8 Mg, Unk) (View Krn125 Review and Krn125 Label ), DEPAS (0.5 Mg, Unk) (View Depas Review and Depas Label ), PRIMPERAN TAB (5 Mg, 3x/day) (View Primperan Tab Review and Primperan Tab Label ), NOVAMIN (5 Mg, 3x/day) (View Novamin Review and Novamin Label ). Patient was hospitalized.

6826998-X | Pneumonia
on Jun 29, 2010 Female patient from JAPAN , 33 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Adriacin (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Adriacin dosage: 50 Mg/m2, Ij. During the same period patient was treated with ENDOXAN (500 Mg/m2, Ij) (View Endoxan Review and Endoxan Label ), TAXOTERE (75 Mg/m2, Ij) (View Taxotere Review and Taxotere Label ), KRN125 (1.8 Mg, Unk) (View Krn125 Review and Krn125 Label ), DEPAS (0.5 Mg, Unk) (View Depas Review and Depas Label ), PRIMPERAN TAB (5 Mg, 3x/day) (View Primperan Tab Review and Primperan Tab Label ), NOVAMIN (5 Mg, 3x/day) (View Novamin Review and Novamin Label ). Patient was hospitalized.

6752088-0 | Appendicitis
on May 19, 2010 Female patient from JAPAN , 42 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Adriacin (View Usage). After Adriacin was administered, patient had the following side effects: appendicitis (What is appendicitis?). Adriacin dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ).

6733704-6 | Appendicitis
Patient was taking Adriacin (View Usage). Patient experienced the following unwanted or unexpected effects: appendicitis (What is appendicitis?) on May 12, 2010 from JAPAN Additional patient health information: Female patient , 42 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Adriacin dosage: . During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ).

6720386-2 | Cardiac Failure Acute
Adverse event was reported on Apr 28, 2010 by a Female patient taking Adriacin (View Usage) (Dosage: 75 Mg, Unk) was diagnosed with non-hodgkin's lymphoma and. Location: JAPAN , 69 years of age, Patient had the following side effects: cardiac failure acute. During the same period patient was treated with ONCOVIN (2 Mg, Unk) (View Oncovin Review and Oncovin Label ), ENDOXAN (1130 Mg, Unk) (View Endoxan Review and Endoxan Label ), PREDONINE (60 Mg, Unk) (View Predonine Review and Predonine Label ), FAMOTIDINE (20 Mg, 2x/day) (View Famotidine Review and Famotidine Label ), COTRIM (1 Df, 1x/day) (View Cotrim Review and Cotrim Label ), CYANOCOBALAMIN (0.5 Mg, 3x/day) (View Cyanocobalamin Review and Cyanocobalamin Label ), MAGNESIUM OXIDE (0.67 G, 3x/day) (View Magnesium Oxide Review and Magnesium Oxide Label ).

6706931-1 | Cystitis
on Apr 21, 2010 Female patient from JAPAN , 40 years of age, was diagnosed with breast cancer (What is breast cancer?), neutropenia and was treated with Adriacin (View Usage). After Adriacin was administered, patient had the following side effects: cystitis. Adriacin dosage: 73 Mg, Unk. During the same period patient was treated with PEGFILGRASTIM (6 Mg, Unk) (View Pegfilgrastim Review and Pegfilgrastim Label ), ENDOXAN (730 Mg, Unk) (View Endoxan Review and Endoxan Label ), TAXOTERE (109 Mg, Unk) (View Taxotere Review and Taxotere Label ), LOXONIN (100 Mg, X 3/day) (View Loxonin Review and Loxonin Label ), TAKEPRON (15 Mg,x 1/day) (View Takepron Review and Takepron Label ), GLYCYRON (6 Dfx 1/day) (View Glycyron Review and Glycyron Label ). Patient was hospitalized.

6706282-5 | Cardiac Failure Acute
on Apr 23, 2010 Female patient from JAPAN , 69 years of age, was diagnosed with lymphoma (What is lymphoma?) and was treated with Adriacin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure acute. Adriacin dosage: Injection. During the same period patient was treated with ONCOVIN (Injection) (View Oncovin Review and Oncovin Label ), ENDOXAN (Injection) (View Endoxan Review and Endoxan Label ), PREDONINE (Injection) (View Predonine Review and Predonine Label ).

6673561-X | Bone Marrow Failure, Liver Disorder
Patient was taking Adriacin (View Usage). Patient had the following side effects: bone marrow failure, liver disorder on Mar 26, 2010 from JAPAN Additional patient health information: Male patient , 67 years of age, was diagnosed with lymphoma (What is lymphoma?) and. Adriacin dosage: 70 Mg, Unk. During the same period patient was treated with ONCOVIN (2 Mg, Unk) (View Oncovin Review and Oncovin Label ), CYCLOPHOSPHAMIDE (1000 Mg, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDONINE (100 Mg, 1x/day) (View Predonine Review and Predonine Label ), RAMOSETRON HYDROCHLORIDE (0.1 Mg, Unk) (View Ramosetron Hydrochloride Review and Ramosetron Hydrochloride Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ), EUGLUCON (Unk) (View Euglucon Review and Euglucon Label ), BASEN (Unk) (View Basen Review and Basen Label ).

6670679-2 | Appendicitis
Adverse event was reported on Apr 02, 2010 by a Female patient taking Adriacin (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 42 years of age, After Adriacin was administered, patient had the following side effects: appendicitis (What is appendicitis?). During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

6631726-7 | Bone Marrow Failure, Liver Disorder
on Mar 04, 2010 Male patient from JAPAN , 67 years of age, was diagnosed with lymphoma (What is lymphoma?) and was treated with Adriacin (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, liver disorder. Adriacin dosage: 70 Mg, Unk. During the same period patient was treated with ONCOVIN (2 Mg, Unk) (View Oncovin Review and Oncovin Label ), ENDOXAN (1000 Mg, Unk) (View Endoxan Review and Endoxan Label ), PREDONINE (100 Mg, 1x/day) (View Predonine Review and Predonine Label ), RAMOSETRON HYDROCHLORIDE (0.1 Mg, Unk) (View Ramosetron Hydrochloride Review and Ramosetron Hydrochloride Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ), EUGLUCON (Unk) (View Euglucon Review and Euglucon Label ), BASEN (Unk) (View Basen Review and Basen Label ).

6610590-6 | Bone Marrow Failure, Liver Disorder
on Feb 18, 2010 Male patient from JAPAN , 67 years of age, was diagnosed with lymphoma (What is lymphoma?) and was treated with Adriacin (View Usage). Patient had the following side effects: bone marrow failure, liver disorder. Adriacin dosage: 70 Mg, Unk. During the same period patient was treated with ONCOVIN (2 Mg, Unk) (View Oncovin Review and Oncovin Label ), ENDOXAN (1000 Mg, Unk) (View Endoxan Review and Endoxan Label ), PREDONINE (100 Mg, 1x/day) (View Predonine Review and Predonine Label ), RAMOSETRON HYDROCHLORIDE (0.1 Mg, Unk) (View Ramosetron Hydrochloride Review and Ramosetron Hydrochloride Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ), EUGLUCON (Unk) (View Euglucon Review and Euglucon Label ), BASEN (Unk) (View Basen Review and Basen Label ).

6608966-6 | Convulsion, Loss Of Consciousness, Paralysis
Patient was taking Adriacin (View Usage). After Adriacin was administered, patient had the following side effects: convulsion, loss of consciousness, paralysis (What is paralysis?) on Feb 17, 2010 from JAPAN Additional patient health information: Male patient , 60 years of age, was diagnosed with pleural effusion and. Adriacin dosage: 30 Mg, Route: Pl. During the same period patient was treated with PICIBANIL (10 Df, Route: Pl) (View Picibanil Review and Picibanil Label ).

6546827-1 | Allergic Cystitis
Adverse event was reported on Jan 12, 2010 by a Male patient taking Adriacin (View Usage) (Dosage: 30 Mg, 1x/day) was diagnosed with bladder cancer (What is bladder cancer?) and. Location: JAPAN , 61 years of age, Patient experienced the following unwanted or unexpected effects: allergic cystitis. During the same period patient was treated with CEFAZOLIN SODIUM (1 G, 2x/day Ij) (View Cefazolin Sodium Review and Cefazolin Sodium Label ), FENTANYL (0.1 Mg, Ij) (View Fentanyl Review and Fentanyl Label ), SALOBEL (100 Mg, 1x/day) (View Salobel Review and Salobel Label ), NEORAL (50 Mg, 2x/day) (View Neoral Review and Neoral Label ).

6534780-6 | Tumour Lysis Syndrome
on Dec 28, 2009 Male patient from JAPAN , 51 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Adriacin (View Usage). Patient had the following side effects: tumour lysis syndrome. Adriacin dosage: 16 Mg, 1x/day. During the same period patient was treated with ONCOVIN (0.4 Mg, 1x/day) (View Oncovin Review and Oncovin Label ), DECADRON (40 Mg, 1x/day Ij) (View Decadron Review and Decadron Label ), SELBEX (50 Mg, 3x/day) (View Selbex Review and Selbex Label ), SENNARIDE (24 Mg, 1x/day) (View Sennaride Review and Sennaride Label ), MEIACT (100 Mg, 3x/day) (View Meiact Review and Meiact Label ), TORASEMIDE (4 Mg, 1x/day) (View Torasemide Review and Torasemide Label ), LOXONIN (60 Mg, 3x/day) (View Loxonin Review and Loxonin Label ), MAXIPIME (1 G, 2x/day Ij) (View Maxipime Review and Maxipime Label ). Patient was hospitalized.

6521515-6 | Allergic Cystitis
on Dec 18, 2009 Male patient from JAPAN , 73 years of age, was diagnosed with bladder cancer (What is bladder cancer?) and was treated with Adriacin (View Usage). After Adriacin was administered, patient had the following side effects: allergic cystitis. Adriacin dosage: 30 Mg. During the same period patient was treated with NICARPINE (2 Mg) (View Nicarpine Review and Nicarpine Label ), VOLTAREN (25 Mg) (View Voltaren Review and Voltaren Label ), CEFAZOLIN SODIUM (1 G, 2x/day) (View Cefazolin Sodium Review and Cefazolin Sodium Label ).

6521052-9 | Venous Thrombosis
Patient was taking Adriacin (View Usage). Patient experienced the following unwanted or unexpected effects: venous thrombosis on Dec 17, 2009 from JAPAN Additional patient health information: Female patient , 66 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Adriacin dosage: Injection. During the same period patient was treated with CYCLOPHOSPHAMIDE (Injection) (View Cyclophosphamide Review and Cyclophosphamide Label ).

6520912-2 | Allergic Cystitis
Adverse event was reported on Dec 17, 2009 by a Male patient taking Adriacin (View Usage) (Dosage: Unk) was diagnosed with bladder cancer (What is bladder cancer?) and. Location: JAPAN , 61 years of age, Patient had the following side effects: allergic cystitis.

6520559-8 | Tumour Lysis Syndrome
on Dec 18, 2009 Male patient from JAPAN , 51 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Adriacin (View Usage). After Adriacin was administered, patient had the following side effects: tumour lysis syndrome. Adriacin dosage: Unk. During the same period patient was treated with ONCOVIN (Unk) (View Oncovin Review and Oncovin Label ), DEXAMETHASONE (Unk) (View Dexamethasone Review and Dexamethasone Label ).

6465049-6 | Nasal Sinus Cancer, Neoplasm Malignant
on Nov 18, 2009 Male patient from JAPAN , 82 years of age, was diagnosed with b-cell small lymphocytic lymphoma and was treated with Adriacin (View Usage). Patient experienced the following unwanted or unexpected effects: nasal sinus cancer, neoplasm malignant. Adriacin dosage: Ij (injection). During the same period patient was treated with ENDOXAN (Ij (injection)) (View Endoxan Review and Endoxan Label ), ONCOVIN (Ij (injection)) (View Oncovin Review and Oncovin Label ).

6465048-4 | Large Intestine Carcinoma, Neoplasm Malignant
Patient was taking Adriacin (View Usage). Patient had the following side effects: large intestine carcinoma, neoplasm malignant on Nov 18, 2009 from JAPAN Additional patient health information: Male patient , 70 years of age, was diagnosed with extranodal marginal zone b-cell lymphoma (malt type) and. Adriacin dosage: Ij (injection). During the same period patient was treated with ENDOXAN (Injection) (View Endoxan Review and Endoxan Label ), ONCOVIN (Injection) (View Oncovin Review and Oncovin Label ).

6465047-2 | Neoplasm Malignant, Oesophageal Carcinoma, Ureteric Cancer
Adverse event was reported on Nov 18, 2009 by a Male patient taking Adriacin (View Usage) (Dosage: Ij (injection)) was diagnosed with diffuse large b-cell lymphoma and. Location: JAPAN , 64 years of age, After Adriacin was administered, patient had the following side effects: neoplasm malignant, oesophageal carcinoma, ureteric cancer. During the same period patient was treated with ENDOXAN (Ij (injection)) (View Endoxan Review and Endoxan Label ), ONCOVIN (Ij (injection)) (View Oncovin Review and Oncovin Label ).

6465046-0 | Gingival Cancer, Neoplasm Malignant
on Nov 18, 2009 Male patient from JAPAN , 49 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Adriacin (View Usage). Patient experienced the following unwanted or unexpected effects: gingival cancer, neoplasm malignant. Adriacin dosage: Ij (injection). During the same period patient was treated with ENDOXAN (Ij (injection)) (View Endoxan Review and Endoxan Label ), ONCOVIN (Ij (injection)) (View Oncovin Review and Oncovin Label ).

6427196-4 | Gingival Cancer, Neoplasm Malignant
on Oct 23, 2009 Male patient from JAPAN , 49 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Adriacin (View Usage). Patient had the following side effects: gingival cancer, neoplasm malignant. Adriacin dosage: Ij (injection). During the same period patient was treated with ENDOXAN (Ij (injection)) (View Endoxan Review and Endoxan Label ), ONCOVIN (Ij (injection)) (View Oncovin Review and Oncovin Label ).

6427195-2 | Large Intestine Carcinoma, Neoplasm Malignant
Patient was taking Adriacin (View Usage). After Adriacin was administered, patient had the following side effects: large intestine carcinoma, neoplasm malignant on Oct 23, 2009 from JAPAN Additional patient health information: Male patient , 70 years of age, was diagnosed with extranodal marginal zone b-cell lymphoma (malt type) and. Adriacin dosage: Ij (injection). During the same period patient was treated with ENDOXAN (Ij (injection)) (View Endoxan Review and Endoxan Label ), ONCOVIN (Ij (injection)) (View Oncovin Review and Oncovin Label ).

6427194-0 | Nasal Sinus Cancer, Neoplasm Malignant
Adverse event was reported on Oct 23, 2009 by a Male patient taking Adriacin (View Usage) (Dosage: Ij (injection)) was diagnosed with b-cell small lymphocytic lymphoma and. Location: JAPAN , 82 years of age, Patient experienced the following unwanted or unexpected effects: nasal sinus cancer, neoplasm malignant. During the same period patient was treated with ENDOXAN (Ij (injection)) (View Endoxan Review and Endoxan Label ), ONCOVIN (Ij (injection)) (View Oncovin Review and Oncovin Label ).

6427193-9 | Neoplasm Malignant, Oesophageal Carcinoma, Ureteric Cancer
on Oct 23, 2009 Male patient from JAPAN , 64 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Adriacin (View Usage). Patient had the following side effects: neoplasm malignant, oesophageal carcinoma, ureteric cancer. Adriacin dosage: Ij (injection). During the same period patient was treated with ENDOXAN (Ij (injection)) (View Endoxan Review and Endoxan Label ), ONCOVIN (Ij (injection)) (View Oncovin Review and Oncovin Label ).

6427192-7 | Hypovolaemic Shock, Ileus Paralytic, Melaena
on Oct 23, 2009 Male patient from JAPAN , 85 years of age, was diagnosed with lymphoma (What is lymphoma?) and was treated with Adriacin (View Usage). After Adriacin was administered, patient had the following side effects: hypovolaemic shock, ileus paralytic, melaena. Adriacin dosage: 35 Mg/m2, Ij. During the same period patient was treated with ONCOVIN (2 Mg, Ij) (View Oncovin Review and Oncovin Label ), ENDOXAN (525 Mg/m2, Ij) (View Endoxan Review and Endoxan Label ), PREDNISOLONE (100 Mg, Unk) (View Prednisolone Review and Prednisolone Label ).

6393894-4 | Interstitial Lung Disease
Patient was taking Adriacin (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease on Sep 25, 2009 from JAPAN Additional patient health information: Female patient , 89 years of age, was diagnosed with lymphoma (What is lymphoma?) and. Adriacin dosage: 50 Mg, Injection, Unk. During the same period patient was treated with RITUXAN (200 Mg /day, Injection) (View Rituxan Review and Rituxan Label ), ENDOXAN (750 Mg/day, Injection) (View Endoxan Review and Endoxan Label ), ONCOVIN (1.4 Mg/day, Injection) (View Oncovin Review and Oncovin Label ), PREDONINE (30 Mg/day) (View Predonine Review and Predonine Label ).

6371005-9 | Interstitial Lung Disease
Adverse event was reported on Sep 10, 2009 by a Female patient taking Adriacin (View Usage) (Dosage: 50 Mg, Injection, Unk) was diagnosed with lymphoma (What is lymphoma?) and. Location: JAPAN , 89 years of age, Patient had the following side effects: interstitial lung disease. During the same period patient was treated with RITUXAN (200 Mg /day, Injection) (View Rituxan Review and Rituxan Label ), CYCLOPHOSPHAMIDE (750 Mg/day, Injection) (View Cyclophosphamide Review and Cyclophosphamide Label ), ONCOVIN (1.4 Mg/day, Injection) (View Oncovin Review and Oncovin Label ), PREDONINE (30 Mg/day) (View Predonine Review and Predonine Label ).

6370197-5 | Abdominal Pain Upper, Anaemia, Decreased Appetite, Gastrointestinal Neoplasm, Intestinal Obstruction, Non-hodgkin's Lymphoma
on Sep 10, 2009 Female patient from JAPAN , 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Adriacin (View Usage). After Adriacin was administered, patient had the following side effects: abdominal pain upper, anaemia, decreased appetite, gastrointestinal neoplasm, intestinal obstruction, non-hodgkin's lymphoma. Adriacin dosage: 50 Mg/m2. During the same period patient was treated with PREDNISOLONE AND PREDNISOLONE STEAGLATE (100 Mg) (View Prednisolone And Prednisolone Steaglate Review and Prednisolone And Prednisolone Steaglate Label ), RITUXAN (375 Mg/m2) (View Rituxan Review and Rituxan Label ), ENDOXAN (750 Mg/m2) (View Endoxan Review and Endoxan Label ), ONCOVIN (1.4 Mg/m2) (View Oncovin Review and Oncovin Label ). Patient was hospitalized.

6346304-7 | Abdominal Tenderness, Hepatic Neoplasm Malignant Recurrent, Liver Abscess, Procedural Site Reaction, Pyrexia
on Sep 01, 2009 Female patient from JAPAN , 85 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Adriacin (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal tenderness, hepatic neoplasm malignant recurrent, liver abscess, procedural site reaction, pyrexia. Adriacin dosage: 12 Mg, Unk. During the same period patient was treated with MITOMYCIN (Unk) (View Mitomycin Review and Mitomycin Label ), LIPIODOL ULTRA FLUID (1.2 Ml, Unk) (View Lipiodol Ultra-fluid Review and Lipiodol Ultra-fluid Label ), LIPIODOL ULTRA FLUID (1.2 Ml, Unk) (View Lipiodol Ultra-fluid Review and Lipiodol Ultra-fluid Label ), GELATIN (Unk) (View Gelatin Review and Gelatin Label ), ETHANOL (Unk) (View Ethanol Review and Ethanol Label ). Patient was hospitalized.

6336761-4 | Bone Marrow Failure
Patient was taking Adriacin (View Usage). Patient had the following side effects: bone marrow failure on Aug 20, 2009 from JAPAN Additional patient health information: Female patient , 63 years of age, was diagnosed with diffuse large b-cell lymphoma and. Adriacin dosage: . During the same period patient was treated with PREDNISOLONE AND PREDNISOLONE STEAGLATE (View Prednisolone And Prednisolone Steaglate Review and Prednisolone And Prednisolone Steaglate Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), ONCOVIN (View Oncovin Review and Oncovin Label ).

6336751-1 | Myelodysplastic Syndrome
Adverse event was reported on Aug 20, 2009 by a Female patient taking Adriacin (View Usage) (Dosage: ) was diagnosed with diffuse large b-cell lymphoma and. Location: JAPAN , 68 years of age, After Adriacin was administered, patient had the following side effects: myelodysplastic syndrome. During the same period patient was treated with PREDNISOLONE AND PREDNISOLONE STEAGLATE (View Prednisolone And Prednisolone Steaglate Review and Prednisolone And Prednisolone Steaglate Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), RITUXAN (View Rituxan Review and Rituxan Label ).

6317073-1 | Bone Marrow Failure, Sepsis
on Aug 11, 2009 Female patient from JAPAN , 63 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Adriacin (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, sepsis (What is sepsis?). Adriacin dosage: . During the same period patient was treated with PREDNISOLONE AND PREDNISOLONE STEAGLATE (View Prednisolone And Prednisolone Steaglate Review and Prednisolone And Prednisolone Steaglate Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), ONCOVIN (View Oncovin Review and Oncovin Label ).

6317071-8 | Myelodysplastic Syndrome
on Aug 11, 2009 Female patient from JAPAN , 68 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Adriacin (View Usage). Patient had the following side effects: myelodysplastic syndrome. Adriacin dosage: . During the same period patient was treated with PREDNISOLONE AND PREDNISOLONE STEAGLATE (View Prednisolone And Prednisolone Steaglate Review and Prednisolone And Prednisolone Steaglate Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), RITUXAN (View Rituxan Review and Rituxan Label ).

6310446-2 | Liver Abscess
Patient was taking Adriacin (View Usage). After Adriacin was administered, patient had the following side effects: liver abscess on Aug 05, 2009 from JAPAN Additional patient health information: Female patient , 85 years of age, was diagnosed with hepatic neoplasm malignant and. Adriacin dosage: Unk. During the same period patient was treated with MITOMYCIN (Unk) (View Mitomycin Review and Mitomycin Label ), LIPIODOL ULTRA FLUID (Unk) (View Lipiodol Ultra-fluid Review and Lipiodol Ultra-fluid Label ).

6297616-7 | Anaemia, Gastrointestinal Fistula, Intestinal Obstruction
Adverse event was reported on Jul 24, 2009 by a Female patient taking Adriacin (View Usage) (Dosage: 50 Mg/m2) was diagnosed with non-hodgkin's lymphoma and. Location: JAPAN , 60 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, gastrointestinal fistula, intestinal obstruction. During the same period patient was treated with PREDNISOLONE AND PREDNISOLONE STEAGLATE (100 Mg) (View Prednisolone And Prednisolone Steaglate Review and Prednisolone And Prednisolone Steaglate Label ), RITUXAN (375 Mg/m2) (View Rituxan Review and Rituxan Label ), ENDOXAN (750 Mg/m2) (View Endoxan Review and Endoxan Label ), ONCOVIN (1.4 Mg/m2) (View Oncovin Review and Oncovin Label ). Patient was hospitalized.

6279503-3 | Acute Lymphocytic Leukaemia, Neoplasm Malignant
on Jul 13, 2009 Female patient from JAPAN , 60 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Adriacin (View Usage). Patient had the following side effects: acute lymphocytic leukaemia, neoplasm malignant. Adriacin dosage: Unk. During the same period patient was treated with ENDOXAN (Unk) (View Endoxan Review and Endoxan Label ), TAXOTERE (60 Mg/m2, Unk) (View Taxotere Review and Taxotere Label ), TAXOL (Unk, 1/3 Week) (View Taxol Review and Taxol Label ), VINORELBINE (80 Mg/m2, Unk) (View Vinorelbine Review and Vinorelbine Label ), TRASTUZUMAB (1/week) (View Trastuzumab Review and Trastuzumab Label ).

5945618-X | Bone Sarcoma
on Oct 29, 2008 Male patient from JAPAN , child 12 years of age, was diagnosed with rhabdomyosarcoma and was treated with Adriacin (View Usage). After Adriacin was administered, patient had the following side effects: bone sarcoma. Adriacin dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), COSMEGEN (View Cosmegen Review and Cosmegen Label ).

5812366-6 | Delirium
Patient was taking Adriacin (View Usage). Patient experienced the following unwanted or unexpected effects: delirium on Jul 04, 2008 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with chondrosarcoma and. Adriacin dosage: .

5738252-8 | Acute Hepatic Failure, Pancytopenia
Adverse event was reported on May 02, 2008 by a Female patient taking Adriacin (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: JAPAN , 49 years of age, Patient had the following side effects: acute hepatic failure, pancytopenia. During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ). Patient was hospitalized.

5724352-5 | Cardio-respiratory Arrest, Cardiomyopathy
on Apr 14, 2008 Female patient from JAPAN , 33 years of age, was diagnosed with acute myeloid leukaemia and was treated with Adriacin (View Usage). After Adriacin was administered, patient had the following side effects: cardio-respiratory arrest, cardiomyopathy (What is cardiomyopathy?). Adriacin dosage: . Patient was hospitalized.

5521407-5 | Clostridium Difficile Colitis
on Nov 07, 2007 Female patient from JAPAN , 70 years of age, was diagnosed with extranodal nk/t-cell lymphoma, nasal type and was treated with Adriacin (View Usage). Patient experienced the following unwanted or unexpected effects: clostridium difficile colitis. Adriacin dosage: . During the same period patient was treated with LEUNASE (View Leunase Review and Leunase Label ), ENDOXAN (View Endoxan Review and Endoxan Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

5501058-9 | Clostridium Difficile Colitis
Patient was taking Adriacin (View Usage). Patient had the following side effects: clostridium difficile colitis on Oct 17, 2007 from JAPAN Additional patient health information: Female patient , 70 years of age, was diagnosed with extranodal nk/t-cell lymphoma, nasal type and. Adriacin dosage: . During the same period patient was treated with LEUNASE (View Leunase Review and Leunase Label ).